跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
兰释 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fluvoxamine Maleate Tablets
Approved
化学药品
Fluvoxamine Maleate Tablets
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Oct 18, 2022
Approval ID
3c806ee9ecc56e2f
Company
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Type
化学药品
Approval Details
Approval Id
3c806ee9ecc56e2f
Approval Number
国药准字HJ20160193
Generic Name
马来酸氟伏沙明片
Generic Name En
Fluvoxamine Maleate Tablets
Trade Name
兰释
Drug Type
化学药品
Dosage Form
片剂
Strength
50mg
Reg Date
2022-10-18
Expired Date
2027-10-17
Company Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Production Company Name
MYLAN LABORATORIES SAS
Company Detail Path
/organization/abbott-laboratories-singapore-private-limited
Production Company Detail Path
/organization/mylan-laboratories-sas
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 18, 2022
Approval ID
3c806ee9ecc56e2f
Type
化学药品
Back to NMPA Approvals